Study setting and blinding – What are the logistical and organisational
challenges of delivering this trial in the chosen setting?
death
EVENTS
After enrolment one participant was withdrawn prior to randomisation due to an
acute physical deterioration and death. At randomisation five participants
(three intravenous iron, two placebo) were newly referred to the palliative care
service but had yet to meet a palliative care physician. All other participants
were under specialist palliative care services at the point of randomisation.
Blinding was maintained during all infusion events.